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Abstract
Background: Studies that contributed to the epidemiology of nausea and vomiting of pregnancy
have reported conflicting findings, and often failed to account for all possible co-variables necessary
to evaluate the multidimensional associations. The objectives of this study were to: 1) Estimate the
prevalence and the severity of nausea and vomiting of pregnancy during the 1st and the 2nd trimester
of pregnancy, and 2) Identify determinants of presence and severity of nausea and vomiting of
pregnancy during the 1st and 2nd trimesters separately, with a special emphasis on the impact of
race/ethnicity.
Methods:  A prospective study including pregnant women attending the Centre Hospitalier
Universitaire (CHU) Sainte-Justine or René-Laennec clinics for their prenatal care was conducted
from 2004 to 2006. Women were eligible if they were ³ 18 years of age, and £  16 weeks of gestation.
Women were asked to fill out a 1st trimester self-administered questionnaire and were interviewed
over the telephone during their 2nd trimester of pregnancy. Presence of nausea and vomiting of
pregnancy was based on the reporting of pregnant women (yes/no); severity of symptoms was
measured by the validated modified-PUQE index.
Results: Of the 367 women included in the study, 81.2% were Caucasians, 10.1% Blacks, 4.6%
Hispanics, and 4.1% Asians. Multivariate analyses showed that race/ethnicity was significantly
associated with a decreased likelihood of reporting nausea and vomiting of pregnancy (Asians vs.
Caucasians OR: 0.13; 95%CI 0.02–0.73; and Blacks vs. Caucasians OR: 0.29; 95%CI 0.09–0.99).
Conclusion: Our study showed that race/ethnicity was associated with the reporting of nausea
and vomiting of pregnancy in the 1st trimester of pregnancy.
Background
Fifty to ninety percent of pregnant women experience
nausea and vomiting during their first trimester [1]. In
general nausea and vomiting of pregnancy (NVP) appear
between the 4th and 6th week of gestational age, with a
peak observed between week 8 and 12 [2,3]. A more
severe form of NVP, known as hyperemesis gravidarum
(HG), will also occur in 0.5 to 3 percent of pregnancies
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and may lead to hospitalisation [4,5]. The aetiology of
NVP is poorly understood but NVP could be considered as
a multifactorial problem. Proposed theories involve hor-
monal, vestibular system, gastrointestinal, psychological,
hyperolfaction, genetic, and evolutionary factors as possi-
ble causes [6,7].
Studies that contributed to the epidemiology of NVP have
reported conflicting findings, and often failed to account
for all possible co-variables necessary to evaluate the mul-
tidimensional associations [8-12]. For example, whether
race/ethnicity influence NVP is not well established.
While some studies indicate that incidence of NVP differs
according to women's race/ethnicity [13-18], others show
no association [9,19]. The fact that none of these studies
accounted for potential confounders could partly explain
this variability. Moreover, studies did not always have an
explicit and valid classification of race/ethnicity, and
nearly all of them were done on pregnant women with
HG. The reason for the possible association between race/
ethnicity and NVP is unknown but it has been proposed
that differences between racial/ethnic groups could be
accounted by important socioeconomic variables [12].
Only three studies used multivariate analyses to evaluate
the association between race/ethnicity and NVP and they
show contradictory results. The first one failed to demon-
strate a significant relationship between race/ethnicity
and vomiting [12], the second showed that White women
had less NVP than Hispanics and Blacks [11], and the
third one showed that Black women had less NVP than
whites [20]. The racial/ethnic differences in the reporting
of health problems is pivotal in order to find out the rea-
son why patients experience diseases and treatment differ-
ently, and to expand approaches for the improvement of
public health [21-23]. Therefore, a study looking at the
association between race/ethnicity and NVP, accounting
for possible confounders is warranted.
The first objective of this study was to estimate the preva-
lence and the severity of NVP during the 1st and the 2nd tri-
mester of pregnancy according to race/ethnicity.
Furthermore, we sought to identify the determinants of
NVP during the 1st and the 2nd trimester of pregnancy sep-
arately, with a special emphasis on the impact of race/eth-
nicity.
Methods
Study design and study population
We carried out a prospective study of pregnant women
receiving prenatal care at the obstetrics and gynaecology
outpatient clinic of the Centre Hospitalier Universitaire
Sainte-Justine  (CHU Sainte-Justine) or the René-Laennec
outpatient clinic, both affiliated with the University of
Montreal, Quebec, Canada, from October 2004 to March
2006. Women were eligible if they: 1) were at least 18
years of age; 2) were at their first prenatal visit; 3) were
pregnant within 16 weeks of the first day of their last men-
ses; 4) were able to read and understand French or Eng-
lish; and 5) had given their written informed consent.
Ethics approval was obtained from the CHU Sainte-Jus-
tine's ethics committee. The present study design and data
collection were partly described elsewhere [24-27].
Data collection
At the end of their first prenatal visit, eligible women who
accepted to participate were asked to fill out a self-admin-
istered questionnaire (1st  trimester questionnaire) at
home, and return it to the coordinating center at CHU Ste-
Justine within the next seven days. Reminder calls were
made if self-administered questionnaires were not
returned in time. Between weeks 20 and 26 of gestational
age, women were called at home (2nd trimester interview)
in order to collect additional information. The end of the
follow-up was defined as the delivery, where data on preg-
nancy outcomes were available from CHU Sainte-Justine's
medical charts.
Presence and severity of NVP were evaluated in two dis-
tinct gestational periods: The 1st trimester questionnaire
covered the 1st trimester of pregnancy, and the 2nd trimes-
ter interview covered the period between the beginning of
the 2nd trimester and the second interview. Presence of
NVP was self-reported by women as a dichotomous varia-
ble (yes/no). The severity of NVP was measured by the
modified-PUQE which has been validated during the
whole 1st trimester of pregnancy [24]. This index is based
on three physical symptoms: the duration of nausea in
hours, and the number of retching and vomiting episodes
on an average day since the beginning of pregnancy. The
total score can range between 3 and 15, with 3 to 6 repre-
senting mild symptoms, 7 to 12 moderate symptoms, and
13 to 15 severe symptoms. The validation study of the
modified-PUQE did not support the presence of recall
bias in the evaluation of the severity of NVP during the
first trimester of pregnancy[24] Furthermore, NVP severity
in the 2nd trimester of pregnancy was measured by the
modified-PUQE by changing the introduction sentence in
order to cover NVP symptoms during this trimester. Inten-
sity of nausea was estimated using a 1 to 10 visual analog
scale ("no nausea at all" to "unbearable nausea") in the 1st
trimester questionnaire and was verbally self-reported by
women on the same scale in the 2nd trimester telephone
interview. Women were also asked about excessive saliva-
tion experience (spitting). The distress caused by excessive
salivation was measured by a 5-point Likert scale.
Demographic and socio-economic data collected in the 1st
trimester questionnaire included maternal and gesta-
tional age, medication (Rx) insurance plan, work status,
living arrangement, education level, household income,BMC Pregnancy and Childbirth 2009, 9:26 http://www.biomedcentral.com/1471-2393/9/26
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and country of birth. Racial/ethnic groups were defined
based on self-perceived membership in racial/ethnic
groups (White, Chinese, South Asian, Black, Arab/West
Asian, Filipino, South East Asian, Latin American, Japa-
nese, Korean, and Other). Because of small frequencies,
Chinese, South Asian, South East Asian, and Korean
women were regrouped in a broader category. Moreover,
as they are often classified as Caucasians [28], Arab
women (n = 28) were regrouped with white women (n =
270). We are confident that this was the appropriate deci-
sion since prevalence of NVP was similar among women
that were clustered in broader categories. Information on
lifestyle, co-morbidities, pregnancy history, maternal
height, and weight was collected in the 1st trimester ques-
tionnaire. Regarding medications used, the 1st trimester
questionnaire included vitamins and oral contraceptives
(OC) use, and medications use for NVP in the 1st trimester
of pregnancy, including non pharmacological methods.
In addition to NVP status in the 2nd trimester of preg-
nancy, data on gestational age, maternal weight gain, and
comorbidities during pregnancy were collected.
Statistical analysis
Descriptive statistics were used to estimate the prevalence
and the severity of NVP during the 1st and the 2nd trimester
of pregnancy. NVP status in the 1st trimester of pregnancy
among racial/ethnic groups were compared using Fisher's
exact tests, and ANOVA when appropriate; if significant,
additional analyses for specific pairwise comparisons
were used. Furthermore, univariate and multivariate logis-
tic regression models were used to identify determinants
of NVP in the 1st and the 2nd trimester of pregnancy sepa-
rately. All socio-demographic variables were included in
the multivariate models. Co-variables were selected on the
basis of the published literature and their association with
the outcome (NVP) in the univariate regression models (p
£  0.15 included). In order to evaluate the impact of the
presence of NVP in previous pregnancies on NVP in the 1st
trimester of subsequent pregnancies, the same multivari-
ate logistic regression model was used in the subgroup of
multigravida women. Since foetal sexual differentiation
occurs between the 7th and 9th week of gestational age
[29], sex of the newborn were included when identifying
determinants of NVP in the 2nd trimester of pregnancy. In
cohort studies, when the outcome of interest is common,
the adjusted odds ratio from the logistic regression may
exaggerate a risk association[30] However, correction
methods to address this issue can be complex or become
inefficient when several variables are included in the
model[30] Because identification of predictors is more
important than quantification in the case of our study, we
did not achieve a correction of odds ratios. Subsequently,
univariate and multivariate ordinal regression models
were used to identify determinants of NVP severity in the
1st trimester of pregnancy. Medications and non-pharma-
cological methods used to ease NVP were added in the
final model. Significance was computed at p < 0.05. All
statistical analyses were performed using SAS Version 8.02
(SAS Institute, NC, USA).
Results
A detailed flow-chart of the recruitment, the refusals, and
the follow-up is presented in Figure 1. Our study popula-
tion consisted of 367 pregnant women recruited between
2004 and 2006. Maternal characteristics including race/
ethnicity and NVP status of the study population are pre-
sented in Table 1. In the 1st trimester of pregnancy, 78.5%
of women reported NVP. In this group, 52.2% experi-
enced mild NVP, 45.3% moderate NVP, and 2.5% severe
NVP. In addition, 26% of pregnant women reporting NVP
also reported excessive salivation during the 1st trimester
of pregnancy, and the majority of them were distressed by
this situation (Table 1). When asking what women had
used in their first trimester to ease nausea and vomiting,
20.4% of them reported having used medications, and
17.9% non-pharmacological methods. As for the 2nd tri-
mester of pregnancy, 40.1% of women reported NVP
(data not showed). Among them, 63.3% experienced
mild NVP, 35.9% moderate NVP, and 0.8% severe NVP.
Intensity of nausea and excessive salivation experience
was similar to what had been reported in the 1st trimester
of pregnancy. Globally, in our study population, 41.1% of
women reported NVP in the 1st trimester of pregnancy
only, 1.3% in the 2nd trimester of pregnancy only, and
38.9% in both of these two gestational periods.
As showed in Table 2, the reporting of NVP symptoms was
not significantly different between racial/ethnic groups (p
= 0.06). However, pairwise comparisons showed that
NVP was significantly more prevalent in Hispanic
(94.1%) women compared to Asians (60%; p < 0.05).
Proportion of women reporting excessive salivation in the
1st trimester of pregnancy was higher in Blacks (79.2%)
than in Caucasians or Hispanics (Caucasians 19.6%, His-
panics 35.7%; p < 0.05).
Multivariate analyses [see Additional file 1] showed that
race/ethnicity (Asians vs. Caucasians, and Blacks vs. Cau-
casians), household income (40000–79999 vs. < 40000
cdn$/yr), and OC use in the six months before pregnancy
were significantly associated (p < 0.05) with a decreased
likelihood of reporting NVP. In the 303 multigravida
women, nausea in previous pregnancies was significantly
associated with an increased likelihood to report NVP in
the 1st trimester of pregnancy (OR: 3.17; 95%CI 1.25–
8.03).
The 2nd trimester interview data were available for 319 of
the 367 (87%) women of the study population. Reasons
for which women were excluded from the 2nd trimester
analysis are presented in Figure 1. Multivariate models
(not showed in table form) showed that greater gesta-BMC Pregnancy and Childbirth 2009, 9:26 http://www.biomedcentral.com/1471-2393/9/26
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tional age at the 2nd trimester interview (OR: 0.89; 95%CI
0.79–1.00), exercise during the 1st trimester of pregnancy
(OR: 0.49; 95%CI 0.24–0.98), coffee drinking before
pregnancy (OR: 0.32; 95%CI 0.12–0.89), and weight gain
during the 1st trimester (OR: 0.73; 95%CI 0.61–0.88)
were significantly associated with a decreased likelihood
of reporting NVP in the 2nd trimester of pregnancy. Pres-
ence of NVP during the 1st trimester of pregnancy (OR:
14.80; 95%CI 4.48–48.95), and female foetus gender
(OR: 2.08; 95%CI 1.11–3.90) were significantly associ-
ated with an increased likelihood of reporting NVP in the
2nd trimester of pregnancy. Race/ethnicity was not a deter-
minant of NVP in the 2nd trimester of pregnancy.
Multivariate analyses [see Additional file 2] showed that
being born outside Canada, using medications to ease
NVP, using non-pharmacological methods to ease NVP,
and parity (2 or more children vs. 0), were significantly
associated (p < 0.05) with more severe NVP symptoms
during the 1st trimester of pregnancy. Race/ethnicity was
not found to be associated with NVP severity in the 1st tri-
mester of pregnancy.
Discussion
In the 1st  trimester of pregnancy, 78.5% of women
reported NVP; this prevalence decreased to 40.1% at the
beginning of the 2nd trimester of pregnancy. Our study
Table 1: Maternal characteristics and NVP status during pregnancy.
NVP status n = 367 1st trimester of pregnancy a
Maternal age-yr (mean ± SD) 31.74 ± 4.70
Gestational Age -wk (mean ± SD) 11.03 ± 1.84
Race/ethnicity- n (%)
Caucasian 298 (81.20)
Asian 15 (4.09)
Black 37 (10.08)
Hispanic 17 (4.63)
NVP - n (%)
Yes 288 (78.47)
No 79 (21.53)
Severity of NVP – n (%)
Mild 145 (52.16)
Moderate 126 (45.32)
Severe 7( 2 . 5 2 )
Intensity of nausea (range 0–10b) – (mean ± SD) 4.69 ± 2.48
Excessive salivation- n (%) 73 (25.98)
Distress caused by excessive salivation- n (%)
Not at all 7( 9 . 7 2 )
Slightly 24 (33.33)
Moderatly 17 (23.61)
Greatly 7( 9 . 7 2 )
Unbearable 17 (23.61)
Medications use to treat NVP in 1st trimesterc – n (%) 57 (20.36)
Non-pharmacological methods use for NVP in 1st trimesterd–n (%) 50 (17.86)
NVP = Nausea and vomiting of pregnancy
a Missing values in the 1st trimester questionnaire: Severity of NVP (n = 10); Excessive salivation (n = 7); Distress caused by excessive salivation (n = 
1); medications and non-pharmacological methods use for NVP (n = 8).
b 0 represented "no nausea at all"and 10 represented "unbearable nausea".
c Medications reported to be used in the 1st trimester of pregnancy to treat NVP were mostly (86%) the combination doxylamine/pyridoxine. 
Women also reported using metoclopramide, dimenhydrinate, hydroxyzine, meclizine, acetaminophen or acid reflux therapies.
d Non-pharmacological methods used in the 1st trimester of pregnancy included lifestyle and dietary changes, and the use of ginger, acupressure, 
homeopathic products, herbal teas, mint or lemon.BMC Pregnancy and Childbirth 2009, 9:26 http://www.biomedcentral.com/1471-2393/9/26
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Study population recruitment and follow-up Figure 1
Study population recruitment and follow-up. *Maternal and gestational age at inclusion.
Women enrolled (n=474)
Questionnaire  received  = 77.4 3 %
1st trimester of pregnancy analysis (n=367)
2
nd trimester of pregnancy analysis (n=319)
Pregnancy outcomes analysis (n=356)
Total
72 .39  %
Refused to participate (n=33)
Mean matern al  a ge* =  3 1.4  ±5 .1
Mean gestatio nal age*   = 10.7 ±2.1
3 (9.4) Spouse refused
4 ( 12.5 ) Precarious preg nan cy/Many spo nta neo us 
a b or t ion s in   t he  p a st
5 ( 15.6 ) Moving
6 ( 18.8 ) C onf iden ti ali ty 
14 (4 3.8) Lack  of time/not in terested
n (%) R eas on s      n  =3 2       (1  m iss in g)
Did not returned their questionnaire (n=107)
1 (0.9) Spouse refused
2 (1.9) No longer followed  at the partici pating clinics
9 (8.4) Lack of  time
9 (8.4) End of pregnancy
86 (80 .4) Did not sen d the ir questio nnaire e ven   a fter a 
remind er ca ll
n (%) Rea son s     n =1 07      
Excluded from the 2
ndtrimester analysis (n=48)
1 (2.1) Already delive red (Great prema turity)
18 (37.5) Pregn ancy ende d
21 (43.7) Never joined/no  answer
8 (16.7) Wrong phone number
n (%) Reasons      
Excluded from the pregnancy outcomes analysis 
(n=11)
3 (27.3) No  trace 
8 (72.7) Move d a nd did not gave birth in   CHU 
Sainte -Justine
n (%) Reasons      
Eligible woman (n=507)
Study population (n=367)
Mean maternal age*= 31 .7 ± 4. 7
Mean gestation al  a ge* = 11.0 ± 1.8
Enrolment = 93.49  %BMC Pregnancy and Childbirth 2009, 9:26 http://www.biomedcentral.com/1471-2393/9/26
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showed that when potential confounders are taken into
account, race/ethnicity is associated with the reporting of
NVP in the 1st trimester of pregnancy (Black and Asian
women being less likely to report NVP than Caucasian
women).
Importance of race/ethnicity
In our study population, prevalence of NVP in the 1st tri-
mester of pregnancy was comparable to what has been
reported in the general population (50–90%) [1]. Our
data showed that Black and Asian women are less likely to
have 1st trimester NVP. Only three previous studies used
multivariate analysis when evaluating the association
between race/ethnicity and NVP. The first one, conducted
in 1985, focused on vomiting symptoms without
accounting for nausea, and failed to demonstrate a signif-
icant association [12]. The second one (1988), showed
that White women had less NVP than non-Whites [11].
Only the third one is not in opposition with our findings,
showing that Black women are less likely to have NVP
than Whites [20]. Different study populations, study
designs, evaluations of NVP symptoms, and confounders
considered could partly explain disparity between our
results and previous researches. As stated earlier, the etio-
logic explanation for the racial/ethnic variability in NVP
prevalence is unknown. Nevertheless, we are confident
that the association between race/ethnicity and 1st trimes-
ter NVP found in this study was not due to sociodemo-
graphic differences between the groups since potential
confounding factors were considered and adjusted for.
However, since a relationship between dietary composi-
tion and NVP has previously been reported [31], we can-
not exclude the possibility of such racial/ethnic
differences in our study. Moreover, it is possible that race/
ethnicity affects the reporting (ex: different cultural
acceptability) of NVP. Globally, we have to point out that
our study cannot be definitive in this area because of
small frequencies in some of the racial/ethnic groups, and
considering the borderline odds ratios for Black women.
Although further studies are needed to confirm this result,
our findings have some clinical implications regarding
specific groups of patients where management of NVP
should be optimised.
Excessive salivation was found to be distressful to a major-
ity of pregnant women suffering from NVP. Clinical
observations generated the hypothesis that Black women
suffering from HG often experience this symptom. As
expected, the current study showed that Black women
having NVP are more likely to report excessive salivation
and spitting in the 1st trimester of pregnancy as compared
to Asian, Hispanic, and Caucasian women. We still do not
know whether race/ethnicity affects only the reporting of
excessive salivation (ex: different cultural acceptability),
or if there is a true physiological difference between racial/
ethnic groups.
Other determinants of NVP
It has been previously reported that low socioeconomic
status was associated with NVP [6]. Our results suggest
that women having a family income ranging from 40000
to 79999 cdn$/y are less likely to have NVP in the 1st tri-
mester of pregnancy than women with lower household
income (<40000 cdn$/y). In contrast, a study conducted
in 2000 in Quebec, Canada, found that household
income ranging from 30000 to 40000 cdn$/y was a deter-
minant of NVP in the 1st trimester of pregnancy (vs. <30
000 or >40 000 cdn$/y) [32]. The different definitions of
household income categories make it difficult to do a
comparative interpretation of our results, and to establish
the generalizability of the association between household
income and NVP. Our study also showed that OC use in
the six months prior to pregnancy decreased the likeli-
hood of reporting NVP in the 1st trimester. On the other
Table 2: Prevalence and severity of NVP in the 1st trimester of pregnancy according to race/ethnicity.
Race/ethnicity n 
(%)
Prevalencea n = 288 Severityb Intensity of 
nauseac
(mean ± SD)
Excessive 
salivation 
experienced
Mild n = 145 Moderate n = 126 Severe n = 7
Caucasian n = 298 237(79.53) 123 (52.79) 105 (45.06) 5 (2.15) 4.55 ± 2.41 46 (19.57)
Asian n = 15 9 (60.00) 4 (50.00) 4 (50.00) 0 5.17 ± 2.79 3 (37.50)
Black n = 37 26 (70.27) 11 (45.83) 11 (45.83) 2 (8.33) 5.40 ± 2.88 19 (79.17)
Hispanic n = 17 16 (94.12) 7 (53.85) 6 (46.15) 0 5.13 ± 2.68 5 (35.71)
a Fisher's exact test: p = 0.06 (Pairwise comparisons p < 0.05: Asian vs Hispanic)
b Fisher's exact test: p = 0.66
c ANOVA: p = 0.34
d Fisher's exact test: p < 0.0001 (Pairwise comparisons p < 0.05: Black vs Caucasian and Black vs Hispanic)BMC Pregnancy and Childbirth 2009, 9:26 http://www.biomedcentral.com/1471-2393/9/26
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side, an earlier study reported that a longer OC use prior
to pregnancy increased NVP severity [31]. However, since
our data did not provide a measure of the duration of OC
use, a comparison is not possible. Finally, our data are
consistent with published findings regarding nausea in
previous pregnancies as a predictor of NVP in subsequent
pregnancies. [11,32] Few studies have looked at reporting
of NVP in the 2nd trimester of pregnancy specifically [33].
In our study, longer gestational age at the 2nd trimester
interview was associated with a decreased likelihood of
reporting NVP in the 2nd trimester of pregnancy (median
gestational age at interview = 21 weeks of pregnancy).
Since most of the NVP symptoms disappear by the 20th
week of gestation [2], it is normal to see that the more a
woman progresses in her pregnancy, the less NVP she will
experience. In addition, our results support the reported
associations between NVP and smaller weight gain in
pregnancy [8] or female fetal gender [10,17]. In contrast
with studies in other populations [31,34], we found that
coffee drinking before pregnancy and exercise during
pregnancy decreased the likelihood of reporting NVP in
the 2nd trimester of pregnancy.
As for the severity of NVP, our study suggests that severe
NVP symptoms are more common among women who
were born outside Canada. This finding is the generalisa-
tion of an earlier study who found that women who were
born outside Quebec are more likely to have HG, a severe
form of NVP [16]. In our study, multiparity was a determi-
nant of more severe NVP symptoms during the 1st trimes-
ter of pregnancy, which is consistent with the existing
literature [8,35,36]. Medications or non-pharmacological
methods use to ease NVP symptoms were also found to be
associated with more severe NVP in the 1st trimester of
pregnancy. As we can expect, the decision to use medica-
tions or non-pharmacological methods to alleviate NVP
can be associated with more severe NVP. However, since
medications or non-pharmacological methods use can
influence or be the consequence of NVP severity, we can-
not exclude the possibility of a protopathic bias here.
Globally, discrepancies between our results and what is
found in the literature might be partly explained by study
population differences, different definitions of covariates
and NVP measures, methodological designs, possibility of
type I and type II errors, and confounding factors consid-
ered in the statistical analysis.
Strengths and limitations
Because patients experiencing NVP could be more likely
to enrol in studies like ours, the study was presented to
women as a general evaluation of quality of life during
pregnancy without focusing specifically on NVP, thus
reducing selection bias. Furthermore, women who refused
to participate were comparable to women enrolled in the
study regarding maternal and gestational age. Recall bias
should be minimised because of the use of a validated
NVP questionnaire and because women were asked about
recent life-style and health information. However, like in
other surveys, there may be under-reporting of smoking
and alcohol use during pregnancy in our study since these
behaviours are known to affect pregnancy outcome and
are considered socially undesirable [37]. Regarding racial/
ethnic categorisation, we cannot exclude the possibility of
non differential misclassification. Moreover, given that at
the time of analyses, clustering of some racial/ethnic
groups in broader categories was made, the applicability
of our results to underrepresented racial/ethnic groups
could be limited. It remains however that race/ethnicity is
essential in epidemiologic studies in order to make and
explore hypotheses on risk factors and to expand
approaches for the improvement of public health [21].
One limitation of our study is that we did not achieve a
global 2nd trimester of pregnancy measure of the preva-
lence and severity of NVP. Because 2nd trimester interview
covered the period between the 1st trimester questionnaire
and the 2nd trimester interview, we obtained a measure for
the period corresponding to the beginning of the 2nd tri-
mester of pregnancy rather than for the entire 2nd trimes-
ter. Since NVP symptoms normally disappear by the 20th
week of gestation [2], we probably obtained a overestima-
tion of the prevalence and the severity of NVP in the 2nd
trimester of pregnancy. Finally, missing values are not a
major concern in our study because less than 3% of differ-
ent maternal characteristic variables were missing.
As for external validity, we feel confident that our study
population is representative of the Montreal population.
The high degree of racial/ethnic diversity of our region
provides a greater generalizability of our results. Moreo-
ver, the majority of women in our study population were
Caucasians. Consequently, it improves the external valid-
ity of our results to the Canadian population. In fact, in
2001 less than 15% of the Canadian population were
from a visible minority group [38]. The high education
level and the high proportion of women having a house-
hold income greater than $80,000/year, which can be
explained by the geographic location of the René-Laennec
clinic (provided 63% of our study cohort), could however
limit the external validity of our study. Finally, because we
achieved more than one recruitment site, we are confident
that our study cohort is representative of the population
of pregnant women receiving prenatal care without an
overrepresentation of high-risk pregnancies.
Conclusion
NVP are a significant health problem in pregnancy. Our
study suggests that Black and Asian women have less NVP
in the 1st trimester of pregnancy than Caucasians. We also
showed that race/ethnicity affects reporting of other con-BMC Pregnancy and Childbirth 2009, 9:26 http://www.biomedcentral.com/1471-2393/9/26
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ditions associated with NVP like excessive salivation. Our
results can contribute to existing literature regarding dis-
ease aetiology and are relevant for targeting specific
groups of patients such as Caucasian or multiparous
where management of NVP should be optimised. In fact,
the subject of NVP should be thoroughly investigated in
these groups as for the severity of symptoms, the extent to
which this condition disturbed everyday tasks, or the need
for treatment. Since the association between race/ethnic-
ity and NVP has not been extensively studied, further
studies are needed to validate our findings.
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